C
CG Oncology D
D
CGON
61.580
USD
1.05
(1.73%)
مفتوح الان
حجم التداول
41,911
الربح لكل سهم
-2
العائد الربحي
-
P/E
-30
حجم السوق
5,096,265,899
العنوان: CG Oncology
القطاع: Healthcare
الصناعة: Biotechnology
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.